Cargando…
Selective Estrogen Receptor Modulator-Associated Nonalcoholic Fatty Liver Disease Improved Survival in Patients With Breast Cancer: A Retrospective Cohort Analysis
Selective estrogen receptor modulator (SERM)-associated nonalcoholic fatty liver disease (NAFLD) might be related to treatment efficacy in patients with breast cancer because of circulating estrogen antagonism. The aim of the study was to investigate the relationship between NAFLD and survival outco...
Autores principales: | Zheng, Qiufan, Xu, Fei, Nie, Man, Xia, Wen, Qin, Tao, Qin, Ge, An, Xin, Xue, Cong, Peng, Roujun, Yuan, Zhongyu, Shi, Yanxia, Wang, Shusen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616748/ https://www.ncbi.nlm.nih.gov/pubmed/26448028 http://dx.doi.org/10.1097/MD.0000000000001718 |
Ejemplares similares
-
Distribution, clinicopathologic features and survival of breast cancer subtypes in Southern China
por: Xue, Cong, et al.
Publicado: (2012) -
Ovarian Function, Not Age, Predicts the Benefit from Ovarian Suppression or Ablation for Premenopausal Women with Breast Cancer
por: Xue, Cong, et al.
Publicado: (2016) -
Clinicopathological characteristics and survival outcomes in neuroendocrine prostate cancer: A population-based study
por: Zhu, Jiamin, et al.
Publicado: (2021) -
Systemic Therapy Combined with Locoregional Therapy Improved Survival in Oligometastatic Breast Cancer: A Single-Center Retrospective Cohort Study
por: Ma, Yuyu, et al.
Publicado: (2022) -
HER2-positive breast cancer patients receiving trastuzumab treatment obtain prognosis comparable with that of HER2-negative breast cancer patients
por: Qin, Tao, et al.
Publicado: (2013)